Mineralocorticoid receptor antagonism by finerenone is...

  • Main
  • 2020 / 09
  • Mineralocorticoid receptor antagonism by finerenone is...
ESC Heart Failure 2020 / 09

Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy

Lowe, Jeovanna, Kolkhof, Peter, Haupt, Michael J., Peczkowski, Kyra K., Rastogi, Neha, Hauck, J. Spencer, Kadakia, Feni K., Zins, Jonathan G., Ciccone, Pierce C., Smart, Suzanne, Sandner, Peter, Raman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
ESC Heart Failure
DOI:
10.1002/ehf2.12996
Date:
September, 2020
File:
PDF, 4.12 MB
2020
Conversion to is in progress
Conversion to is failed